Cadenza Study: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of BIVV009 in Patients with Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion (BIV009-04)

  • Chunilal, Sanjeev (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/MonH/407
NMA SSA Reference Number: SSA/18/MonH/550
Monash Health Ref: RES-18-0000-286A
Protocol number: BIVV009-04 Version 3 dated 21 March 2018
StatusFinished
Effective start/end date9/08/18 → 8/08/23